Literature DB >> 17111193

Brd2 is a TBP-associated protein and recruits TBP into E2F-1 transcriptional complex in response to serum stimulation.

Jinhong Peng1, Wei Dong, Lu Chen, Tingting Zou, Yipeng Qi, Yingle Liu.   

Abstract

Brd2 is a novel protein kinase and plays a role in cell cycle-responsive transcription. Recent studies show that Brd2 contributes to E2F-1 regulated cell cycle progression. In this process, Brd2 exhibits scaffold or transcriptional adapter functions and mediates recruitment of both E2F-1 transcription factors and chromatin-remodelling activity to the E2F-1-resposive promoter. In the present study, we show that Brd2 is also a TBP-associated protein and a 26 amino acids peptide in the first bromodomain of Brd2 is essential for Brd2-TBP interaction. We found that serum stimulation of serum starved NIH/3T3 cells efficiently induces the formation of the Brd2-E2F-1-TBP complex in vivo. In this process, Brd2 plays a pivotal role in the recruitment of TBP into a E2F-1 transcriptional complex, as tested in overexpression assay and at the endogenous level. Furthermore, the 26 amino acid peptide that mediates Brd2-TBP interaction is proved to be critical for Brd2-dependent transactivation on E2F-1-responsive promoters, and moreover, Brd2 and E2F-1 may cooperatively participate in various serum-induced transactivation processes in Luciferase-reporter assays. Thus taken together, because Brd2 may recruit a HAT in its transactivational complex and E2F-1 has been found to stimulate transcription by recruiting acetyltransferase and cofactors GCN5, we predict that Brd2 and E2F-1 may act in a cooperative way to introduce an optimal environment for TBP binding to the TATA-element of gene promoters.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17111193     DOI: 10.1007/s11010-006-9223-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

1.  The bromodomain: a chromatin-targeting module?

Authors:  F Winston; C D Allis
Journal:  Nat Struct Biol       Date:  1999-07

2.  The bromodomain of Gcn5p interacts in vitro with specific residues in the N terminus of histone H4.

Authors:  P Ornaghi; P Ballario; A M Lena; A González; P Filetici
Journal:  J Mol Biol       Date:  1999-03-19       Impact factor: 5.469

3.  Solution structure and acetyl-lysine binding activity of the GCN5 bromodomain.

Authors:  B P Hudson; M A Martinez-Yamout; H J Dyson; P E Wright
Journal:  J Mol Biol       Date:  2000-12-01       Impact factor: 5.469

4.  Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines.

Authors:  Gerald V Denis; Mark E McComb; Douglas V Faller; Anupama Sinha; Paul B Romesser; Catherine E Costello
Journal:  J Proteome Res       Date:  2006-03       Impact factor: 4.466

5.  The TAF(II)250 subunit of TFIID has histone acetyltransferase activity.

Authors:  C A Mizzen; X J Yang; T Kokubo; J E Brownell; A J Bannister; T Owen-Hughes; J Workman; L Wang; S L Berger; T Kouzarides; Y Nakatani; C D Allis
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

6.  Molecular basis for Gcn5/PCAF histone acetyltransferase selectivity for histone and nonhistone substrates.

Authors:  Arienne N Poux; Ronen Marmorstein
Journal:  Biochemistry       Date:  2003-12-16       Impact factor: 3.162

7.  E mu-BRD2 transgenic mice develop B-cell lymphoma and leukemia.

Authors:  Rebecca J Greenwald; Joseph R Tumang; Anupama Sinha; Nicolas Currier; Robert D Cardiff; Thomas L Rothstein; Douglas V Faller; Gerald V Denis
Journal:  Blood       Date:  2003-10-16       Impact factor: 22.113

8.  Role for Nhp6, Gcn5, and the Swi/Snf complex in stimulating formation of the TATA-binding protein-TFIIA-DNA complex.

Authors:  Debabrata Biswas; Anthony N Imbalzano; Peter Eriksson; Yaxin Yu; David J Stillman
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

9.  Facilitated binding of TATA-binding protein to nucleosomal DNA.

Authors:  A N Imbalzano; H Kwon; M R Green; R E Kingston
Journal:  Nature       Date:  1994-08-11       Impact factor: 49.962

10.  Bromodomain analysis of Brd2-dependent transcriptional activation of cyclin A.

Authors:  Anupama Sinha; Douglas V Faller; Gerald V Denis
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

View more
  28 in total

Review 1.  BET domain co-regulators in obesity, inflammation and cancer.

Authors:  Anna C Belkina; Gerald V Denis
Journal:  Nat Rev Cancer       Date:  2012-06-22       Impact factor: 60.716

2.  Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.

Authors:  Bjoern Chapuy; Michael R McKeown; Charles Y Lin; Stefano Monti; Margaretha G M Roemer; Jun Qi; Peter B Rahl; Heather H Sun; Kelly T Yeda; John G Doench; Elaine Reichert; Andrew L Kung; Scott J Rodig; Richard A Young; Margaret A Shipp; James E Bradner
Journal:  Cancer Cell       Date:  2013-12-09       Impact factor: 31.743

Review 3.  BET proteins in abnormal metabolism, inflammation, and the breast cancer microenvironment.

Authors:  Guillaume P Andrieu; Jordan S Shafran; Jude T Deeney; Kishan R Bharadwaj; Annapoorni Rangarajan; Gerald V Denis
Journal:  J Leukoc Biol       Date:  2018-03-01       Impact factor: 4.962

4.  Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.

Authors:  Saumya Shree Gupta; Tobias Maetzig; Goedele N Maertens; Azar Sharif; Michael Rothe; Magdalena Weidner-Glunde; Melanie Galla; Axel Schambach; Peter Cherepanov; Thomas F Schulz
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

5.  BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.

Authors:  Daniela Boehm; Vincenzo Calvanese; Roy D Dar; Sifei Xing; Sebastian Schroeder; Laura Martins; Katherine Aull; Pao-Chen Li; Vicente Planelles; James E Bradner; Ming-Ming Zhou; Robert F Siliciano; Leor Weinberger; Eric Verdin; Melanie Ott
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

Review 6.  The role of the double bromodomain-containing BET genes during mammalian spermatogenesis.

Authors:  Binyamin D Berkovits; Debra J Wolgemuth
Journal:  Curr Top Dev Biol       Date:  2013       Impact factor: 4.897

7.  Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma.

Authors:  Liang Xu; Ye Chen; Anand Mayakonda; Lynnette Koh; Yuk Kien Chong; Dennis L Buckley; Edwin Sandanaraj; See Wee Lim; Ruby Yu-Tong Lin; Xin-Yu Ke; Mo-Li Huang; Jianxiang Chen; Wendi Sun; Ling-Zhi Wang; Boon Cher Goh; Huy Q Dinh; Dennis Kappei; Georg E Winter; Ling-Wen Ding; Beng Ti Ang; Benjamin P Berman; James E Bradner; Carol Tang; H Phillip Koeffler
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-15       Impact factor: 11.205

8.  Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis.

Authors:  Hiba Mahdi; Benjamin A Fisher; Henrik Källberg; Darren Plant; Vivianne Malmström; Johan Rönnelid; Peter Charles; Bo Ding; Lars Alfredsson; Leonid Padyukov; Deborah P M Symmons; Patrick J Venables; Lars Klareskog; Karin Lundberg
Journal:  Nat Genet       Date:  2009-11-08       Impact factor: 38.330

9.  H2A.Z.1 Monoubiquitylation Antagonizes BRD2 to Maintain Poised Chromatin in ESCs.

Authors:  Lauren E Surface; Paul A Fields; Vidya Subramanian; Russell Behmer; Namrata Udeshi; Sally E Peach; Steven A Carr; Jacob D Jaffe; Laurie A Boyer
Journal:  Cell Rep       Date:  2016-01-21       Impact factor: 9.423

10.  BET Protein BRDT Complexes With HDAC1, PRMT5, and TRIM28 and Functions in Transcriptional Repression During Spermatogenesis.

Authors:  Li Wang; Debra J Wolgemuth
Journal:  J Cell Biochem       Date:  2015-11-26       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.